ContraFect
develops and commercializes biologic antibody therapeutics for the treatment of drug-resistant infectious diseases... Read moreContraFect
develops and commercializes biologic antibody therapeutics for the treatment of drug-resistant infectious diseases... Read more
News
Nov 14, 2023
Marketscreener
ContraFect: ContraFect: Q3 Earnings Snapshot
Oct 16, 2023
Life Care News
ContraFect: ContraFect Announces FDA Clearance of CF-370 IND
Sep 19, 2023
Benzinga
ContraFect: ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
Aug 28, 2023
centralcharts
Press Release: ContraFect : ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
Aug 14, 2023
BioSpace
ContraFect: ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 14, 2023
Yahoo
ContraFect: ContraFect: Q2 Earnings Snapshot
Jun 27, 2023
BioSpace
ContraFect: ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million
Jun 20, 2023
Benzinga
ContraFect: ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company's Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens
Jun 08, 2023
GlobeNewswire
Press Release: ContraFect : ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023
May 15, 2023
MarketScreener
ContraFect: CONTRAFECT CORPORATION SHARES UP 19.9% AFTER Q1 LOSS NARROWS
ContraFect Competitors
1
2
3
4
5
6
7
8
9
10